These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12714123)

  • 1. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.
    Kanazawa H; Asai K; Hirata K; Yoshikawa J
    Am J Med; 2003 Apr; 114(5):354-8. PubMed ID: 12714123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and the pathogenesis of emphysema.
    Wagner PD
    Am J Med; 2003 Apr; 114(5):413-4. PubMed ID: 12714134
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients.
    Asai K; Kanazawa H; Kamoi H; Shiraishi S; Hirata K; Yoshikawa J
    Clin Exp Allergy; 2003 May; 33(5):595-9. PubMed ID: 12752587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.
    Santos S; Peinado VI; Ramirez J; Morales-Blanhir J; Bastos R; Roca J; Rodriguez-Roisin R; Barbera JA
    Am J Respir Crit Care Med; 2003 May; 167(9):1250-6. PubMed ID: 12615615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance between vascular endothelial growth factor and endostatin in emphysema.
    Kanazawa H; Hirata K; Yoshikawa J
    Eur Respir J; 2003 Oct; 22(4):609-12. PubMed ID: 14582912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.
    Kanazawa H; Asai K; Nomura S
    Respir Res; 2007 Mar; 8(1):22. PubMed ID: 17343763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T
    Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor levels in induced sputum and emphysematous changes in smoking asthmatic patients.
    Bae YJ; Kim TB; Moon KA; Lee KY; Park CS; Seo JB; Chae EJ; Moon HB; Cho YS
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):51-6. PubMed ID: 19663127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients.
    Kanazawa H; Hirata K; Yoshikawa J
    Thorax; 2002 Oct; 57(10):885-8. PubMed ID: 12324676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating thrombomodulin levels with exercise in patients with chronic obstructive pulmonary disease.
    Kanazawa H; Asai K; Nomura S
    Respirology; 2007 Sep; 12(5):670-4. PubMed ID: 17875054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine.
    Barczyk A; Pierzchala W; Sozañska E
    Respir Med; 2003 Jun; 97(6):726-33. PubMed ID: 12814161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease].
    Izquierdo JL; Almonacid C; Parra T; Pérez J
    Arch Bronconeumol; 2006 Jul; 42(7):332-7. PubMed ID: 16945263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
    Siddiqui S; Sutcliffe A; Shikotra A; Woodman L; Doe C; McKenna S; Wardlaw A; Bradding P; Pavord I; Brightling C
    J Allergy Clin Immunol; 2007 Oct; 120(4):813-9. PubMed ID: 17610943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis.
    Kanazawa H; Nomura S; Yoshikawa J
    Am J Respir Crit Care Med; 2004 May; 169(10):1125-30. PubMed ID: 15044203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between amphiregulin and airway inflammation in children with asthma and eosinophilic bronchitis.
    Kim KW; Jee HM; Park YH; Choi BS; Sohn MH; Kim KE
    Chest; 2009 Sep; 136(3):805-810. PubMed ID: 19447920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction.
    Bartoli ML; Di Franco A; Vagaggini B; Bacci E; Cianchetti S; Dente FL; Tonelli M; Paggiaro PL
    Respiration; 2009; 77(3):265-72. PubMed ID: 19075557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of placenta growth factor in COPD.
    Cheng SL; Wang HC; Yu CJ; Yang PC
    Thorax; 2008 Jun; 63(6):500-6. PubMed ID: 18202163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.